We are live on ! Find out more
AWM

Aevitas Wealth Management Portfolio holdings

AUM $169M
1-Year Est. Return 9.55%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
-9.55%
3 Year Est. Return
+36.41%
5 Year Est. Return
+72.53%
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$7.71M
Cap. Flow
+$1.15M
Cap. Flow %
1.05%
Top 10 Hldgs %
29.89%
Holding
461
New
33
Increased
162
Reduced
63
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$511K
2
VTV icon
Vanguard Value ETF
VTV
+$489K
3
PEP icon
PepsiCo
PEP
+$236K
4
VB icon
Vanguard Small-Cap ETF
VB
+$129K
5
NVDA icon
NVIDIA
NVDA
+$78K

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$262K
2
VYGR icon
Voyager Therapeutics
VYGR
+$211K
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$188K
4
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$161K
5
BSCM
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
+$92.7K

Sector Composition

Rank Sector Weight
1 Healthcare 12.78%
2 Technology 12.74%
3 Consumer Staples 11.44%
4 Consumer Discretionary 8.84%
5 Financials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUTY icon
301
Fidelity MSCI Utilities Index ETF
FUTY
$2.37B
$17K 0.02%
484
+4
+0.8% +$140
NOV icon
302
NOV
NOV
$7.11B
$17K 0.02%
400
– –
PDT
303
John Hancock Premium Dividend Fund
PDT
$637M
$17K 0.02%
1,050
– –
VWO icon
304
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$17K 0.02%
425
– –
EDIT icon
305
Editas Medicine
EDIT
$402M
$16K 0.01%
500
– –
EEM icon
306
iShares MSCI Emerging Markets ETF
EEM
$28B
$16K 0.01%
371
– –
FISV
307
Fiserv Inc
FISV
$28.9B
$16K 0.01%
200
– –
EFF
308
DELISTED
EATON VANCE FLOATING-RATE INCOME PLUS FUND
EFF
$16K 0.01%
1,000
– –
BR icon
309
Broadridge
BR
$18.3B
$15K 0.01%
116
– –
GE icon
310
GE Aerospace
GE
$377B
$15K 0.01%
268
+42
+19% +$2.59K
PCRX icon
311
Pacira BioSciences
PCRX
$1.05B
$15K 0.01%
300
– –
SGEN
312
DELISTED
Seagen Inc. Common Stock
SGEN
$15K 0.01%
200
– –
TCP
313
DELISTED
TC Pipelines LP
TCP
$15K 0.01%
500
– –
I
314
DELISTED
INTELSAT S. A.
I
$15K 0.01%
500
– –
BMS
315
DELISTED
Bemis
BMS
$15K 0.01%
300
– –
BP icon
316
BP
BP
$107B
$14K 0.01%
+314
New +$13.1K
COR icon
317
Cencora
COR
$62.2B
$14K 0.01%
155
– –
IBB icon
318
iShares Biotechnology ETF
IBB
$9.55B
$14K 0.01%
117
– –
AWR icon
319
American States Water
AWR
$3.45B
$13K 0.01%
220
+1
+0.5% +$60
DELL icon
320
Dell
DELL
$253B
$13K 0.01%
481
– –
HPQ icon
321
HP
HPQ
$25.9B
$13K 0.01%
+500
New +$12.1K
IXJ icon
322
iShares Global Healthcare ETF
IXJ
$4.18B
$13K 0.01%
200
– –
LITE icon
323
Lumentum
LITE
$50.7B
$13K 0.01%
211
– –
PML
324
PIMCO Municipal Income Fund II
PML
$487M
$13K 0.01%
+1,000
New +$13.2K
EA icon
325
Electronic Arts
EA
$52.4B
$12K 0.01%
+100
New +$12.9K
11 12
13
14 15

Similar funds

CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
BA
Bennicas & Associates Portola Valley, California $173M AUM 1.55% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return
RCA
Rex Capital Advisors Providence, Rhode Island $152M AUM 17.51% 1-Year Est. Return
SCM
Snowhook Capital Management New York $187M AUM 31.24% 1-Year Est. Return
WWA
WC Walker & Associates Fullerton, California $189M AUM 16.91% 1-Year Est. Return

Aevitas Wealth Management's Q3 2018 Portfolio in Review

As of Q3 2018, Aevitas Wealth Management held 461 positions worth $110M, up 7.5% from $103M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Aevitas Wealth Management's Q3 2018 filing shows 33 new, 162 increased, 63 reduced and 7 closed positions. Its largest new stake was Weyerhaeuser: 1,110 shares worth $36K. The largest sale was CRISPR Therapeutics, an estimated $262K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Staples.

  • Aevitas Wealth Management's largest Q3 2018 buy was Weyerhaeuser: 1,110 shares worth $36K.
  • Aevitas Wealth Management added most to Microsoft in Q3 2018, an estimated $511K increase.
  • Aevitas Wealth Management's biggest Q3 2018 reduction was CRISPR Therapeutics, cutting an estimated $262K.
  • Aevitas Wealth Management fully exited Wgl Holdings in Q3 2018, selling an estimated $71K.
  • Aevitas Wealth Management's ten largest holdings make up 30% of its $110M portfolio in Q3 2018.
  • Aevitas Wealth Management opened 33 new positions and closed 7 in Q3 2018.
  • Aevitas Wealth Management's portfolio value rose 7.5% quarter-over-quarter to $110M.

Based on Aevitas Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.